Document is current
Any future updates will be listed below
-
Authors
Alfambra, Héctor https://orcid.org/0009-0001-8144-7714
Carbonell, Enric
Vilaseca, Antoni https://orcid.org/0000-0003-0160-620X
- License Information
-
More Information
Article History
Accepted: 2 February 2026
First Online: 20 February 2026
Conflict of interest
: A. Vilaseca is principal author and investigator of the First-in-human TAR-210 trial ( J Clin Oncol 2023;41 suppl 6:TPS583). H. Alfambra and E. Carbonell declare that they have no competing interests.
